Young, I. R., Hall, A. S., Pallis, C. A., Legg, N. J., Bydder, G. M., and Steiner, R. E. (1981) Nuclear magnetic resonance imaging of the brain in multiple sclerosis Lancet 2, 1063-1066 (Pubitemid 11026868)
Sahraian, M. A. and Eshaghi, A. (2010) Role of MRI in diagnosis and treatment of multiple sclerosis Clin. Neurol. Neurosurg. 112, 609-615
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., and Lublin, F. D. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis Ann. Neurol. 50, 121-127
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H. P., and Kappos, L. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann. Neurol. 58, 840-846 (Pubitemid 41746873)
Bakshi, R., Minagar, A., Jaisani, Z., and Wolinsky, J. S. (2005) Imaging of multiple sclerosis: role in neurotherapeutics NeuroRx 2, 277-303 (Pubitemid 40471438)
Laule, C., Vavasour, I. M., and Whittall, K. P. (2003) Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis J. Neurol. 250, 924-931 (Pubitemid 37041022)
Trapp, B. D. and Nave, K. A. (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu. Rev. Neurosci. 31, 247-269
Rommer, P. S. and Stuve, O. (2008) Monoclonal antibodies in the therapy of multiple sclerosis J. Neurol. Suppl. 6, 28-35
Seigneuric, R. and Markey, L. (2010) From Nanotechnology to Nanomedicine: Applications to Cancer Research Curr. Mol. Med. 10, 640-652
Fang, C. and Zhang, M. (2010) Nanoparticle-based theragnostics: integrating diagnostic and therapeutic potentials in nanomedicine J. Controlled Release 146, 2-5
Lublin, F. (2005) History of modern multiple sclerosis therapy Neurology 252, III/3-III/9
Compston, A. (2005) McAlpine's Multiple Sclerosis, 4th ed., Churchill- Livingstone: New York.
Kabat, E. A., Moore, D. H., and Landow, H. (1942) An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins J. Clin. Invest. 21, 571-577
Kurtzke, J. F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33, 1444-1452 (Pubitemid 14237132)
Filippini, G., Brusaferri, F., Sibley, W. A., Citterio, A., Ciucci, G., Midgard, R., and Candelise, L. (2000) Corticosteroids or ACTH for acute exacerbations in multiple sclerosis Cochrane Database Syst. Rev. 4, xxx-xxx
Bornstein, M. B., iller, A., Slagle, S., Weitzman, M., Crystal, H., Drexler, E., Keilson, M., Merriam, A., Wassertheil-Smoller, S., and Spada, V. (1987) A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis New Engl. J. Med. 317, 408-414 (Pubitemid 17131177)
The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis I Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 43, 655-661
The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomised controlled trial Neurology 45, 1277-1285
Herndon, R. M., Richert, J. R., Salazar, A. M., Fischer, J. S., Goodkin, D. E., Granger, C. V., Simon, J. H., and Alam, J. J. (1996) Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann. Neurol. 39, 285-294 (Pubitemid 26100751)
Ford, C. C., Goldstein, J., Lisak, R. P., Myers, L. W., Panitch, H. S., Rose, J. W., and Schiffer, R. B. (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing remitting multiple sclerosis: results of a phase III multicentre double-blind placebo-controlled trial. The Copolymer I Multiple Sclerosis Study Group Neurology 45, 1268-1276
PRISMS Study Group (1998) Randomized double-blind placebo-controlled study of interferon ss-1a in relapsing/remitting multiple sclerosis Lancet 352, 1498-1504
Hartung, H. P., Gonsette, R., and Konig, N. (2002) Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial Lancet 360, 2018-2025 (Pubitemid 36026580)
Polman, H. M., Connor, P. O., and Havrdova, E. (2006) A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis N. Engl. J. Med. 354, 899-910
Kappos, L., Radue, E.-M., and O'Connor, P. (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis N. Engl. J. Med. 362, 387-401
www.mpikg-golm.mpg.de.
Brayner, R. (2008) The toxicological impact of nanoparticles Nano Today 3, 48-55 (Pubitemid 351313714)
Maxwell, J. C. (1871) Theory of Heat, Dover Publications.
Zsigmondy, R. (1914) Colloids and the Ultramicroscope, J. Wiley and Sons, New York.
Thanh, N. T. K. and Green, L. A. W. (2010) Functionalisation of nanoparticles for biomedical applications Nano Today 5, 213-230
Fong, J. and Wood, F. (2006) Nanocrystalline silver dressings in wound management: a review Int. J. Nanomed. 1, 441-449
Takenaka, S., Karg, E., Roth, C., Schultz, H., Ziesenis, A., Heinzman, U., Schramel, P., and Heyder, J. (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats Environ. Health Perspect. 109 (Suppl 4) 547-551 (Pubitemid 32834568)
Kang, S. J., Kim, B. M., Lee, Y. J., and Chung, H. W. (2008) Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes Environ. Mol. Mutagen. 49, 399-405
Kang, S. J., Kim, B. M., Lee, Y. J., Hong, S. H., and Chung, H. W. (2009) Titanium dioxide nanoparticles induce apoptosis through the JNK/p38-caspase-8-Bid pathway in phytohemagglutinin-stimulated human lymphocytes Biochem. Biophys. Res. Commun. 386, 682-687
Long, T. C., Saleh, N., Tilton, R. D., Lowry, G. V., and Veronesi, B. (2006) Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): Implications for nanoparticle neurotoxicity Environ. Sci. Technol. 40, 4346-4352 (Pubitemid 44092366)
Dufour, E. K., Kumaravel, T., Nohynek, G. J., Kirkland, D., and Toutain, H. (2006) Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells Mutat. Res. 607, 215-224 (Pubitemid 44131516)
Mahmoudi, M., Hosseinkhani, M., Boutry, S., Simchi, A., Hosseinkhani, H., Journeay, W. S., Subramani, K., and Laurent, S. (2011) MRI tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine, Chem. Rev. In press. DOI: 10.1021/cr1001832.
Mahmoudi, M., Laurent, S., Azadmanesh, K., and Journeay, W. S. (2011) Effect of nanoparticles on cell-life cycle, Chem. Rev. In revision.
Shi, Y., Wang, F., He, J., Yadav, S., and Wamg, H. (2011) Titanium dioxide nanoparticles cause apoptosisin BEAS-2B cells through the caspase 8/t-Bid-independent mitochondrial pathway Toxicol. Lett. 196, 21-27
Theogaraj, E., Riley, S., Hughes, L., Maier, M., and Kirkland, D. (2007) An investigation of the photo-clastogenic potential of ultrafine titanium dioxide particles Mutat. Res. 634, 205-219 (Pubitemid 47634008)
Warheit, D. B., Reed, K. L., and Webb, T. R. (2003) Pulmonary toxicity studies in rats with triethoxyoctylsilane (OTES)-coated pigment grade titanium dioxide particles: Bridging studies to predict inhalation hazard Exp. Lung Res. 29, 593-606 (Pubitemid 37463930)
Xu, A., Chai, Y., and Hei, T. K. (2009) Genotoxic responses to titanium dioxide nanoparticles and fullerene in gpt delta transgenic MEF cells Part. Fibre Toxicol. 6, 3
Fiorito, S., Serafino, A., Andreola, F., and Bernier, P. (2006) Effects of fullerenes and single-wall carbon nanoubes on murine and human macrophages Carbon 44, 1100-1105 (Pubitemid 43202167)
Gharbi, N., Pressac, M., Hadchouel, M., Szwarc, H., Wilson, S. R., and Moussa, F. (2005) [60] Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity Nano Lett. 5, 2578-2585 (Pubitemid 43088916)
Jia, G., Wang, H., Yan, L., Wang, X., Pei, R., Yan, T., Zhao, Y., and Guo, X. (2005) Cytotoxicity of carbon nanomaterials: Single-wall nanotube, multi-wall nanotube and fullerene Environ. Sci. Technol. 39, 1378-1383 (Pubitemid 40333400)
Bianco, A., Hoebeke, J., Godefroy, S., Chaloin, O., Pantarotto, D., Briand, J. P., Muller, S., Prato, M., and Partidos, C. D. (2005) Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties J. Am. Chem. Soc. 127, 58-59 (Pubitemid 40094363)
Bianco, A. and Prato, M. (2003) Can carbon nanotubes be considered useful tools for biological applications? Adv. Mater. 15, 1765-1768
Huczko, A. and Lange, H. (2001) Carbon nanotubes: experimental evidence for a null risk of skin irritation and allergy Fullerene Sci. Technol. 9, 247-250 (Pubitemid 32697618)
Huczko, A., Lange, H., Calko, E., Grubek-Jaworksa, H., and Droszcz, P. (2001) Physiological testing of carbon nanotubes: Are they asbestos-like? Fullerene Sci. Technol. 9, 251-254 (Pubitemid 32697619)
Ying-ying, G., Tan Xiao-ping, T., Shu-quan, L., and Shang-bin, S. (2004) Effects of La3? doping on MnZn ferrite nanoscale particles synthesized by hydrothermal method J. Cent. South Univ. Technol. (Engl. Ed.) 11, 113-228
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., and Muller, R. N. (2008) Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations and biological applications Chem. Rev. 108, 2064-2110
Pollert, E., Veverka, P., Veverka, M., Kaman, O., Závěta, K., Vasseur, S., Epherre, R., Goglio, G., and Duguet, E. (2009) Search of new core materials for magnetic fluid hyperthermia: Preliminary chemical and physical issues Prog. Solid State Chem. 37, 1-14
Sawatzky, G. A., Van Der Woude, F., and Morrish, A. H. (1968) Cation distributions in octahedral and tetrahedral sites of the ferrimagnetic spinel CoFe2O4 J. Appl. Phys. 39, 1204-1205
Brown, W. F. (1963) Thermal fluctuations of a single-domain particle Phys. Rev. 130, 1677-1686
Kuznetsov, O. A., Sorokina, O. N., Leontiev, V. G., Shlyakhtin, O. A., Kovarski, A. L., and Kuznetsov, A. A. (2007) ESR study of thermal demagnetization processes in ferromagnetic nanoparticles with Curie temperatures between 40 and 60 {ring operator} C J. Magn. Magn. Mater. 311, 204-207 (Pubitemid 46401020)
Pollert, E. (1985) Crystal chemistry of magnetic oxides part 2: Hexagonal ferrites Prog. Cryst. Growth Charact. 11, 155-205 (Pubitemid 16612001)
Auzans, E., Zins, D., Blums, E., and Massart, R. (1999) Synthesis and properties of Mn-Zn ferrite ferrofluids J. Mater. Sci. 34, 1253-1260
Sharma, R. and Chen, C. J. (2009) Newer nanoparticles in hyperthermia treatment and thermometry J. Nanopart. Res. 11, 671-689
Brusentsova, T. N. and Kuznetsov, V. D. (2007) Synthesis and investigation of magnetic properties of substituted ferrite nanoparticles of spinel system Mn1- xZnx[Fe2- yL y]O4 J. Magn. Magn. Mater. 311, 22-25 (Pubitemid 46400982)
Sutariya, G. M., Vincent, D., Bayard, B., Upadhyay, R. V., Noyel, G., and Mehta, R. V. (2003) Magnetic DC field and temperature dependence on complex microwave magnetic permeability of ferrofluids: effect of constituent elements of substituted Mn ferrite J. Magn. Magn. Mater. 260, 42-47
Shuai, J. and Parker, I. (2005) Optical single-channel recording by imaging Ca2+ flux through individual ion channels: theoretical considerations and limits to resolution Cell Calcium 37, 283-299 (Pubitemid 40331447)
Bretcanu, O., Verné, E., Cöisson, M., Tiberto, P., and Allia, P. (2006) Magnetic properties of the ferrimagnetic glass-ceramics for hyperthermia J. Magn. Magn. Mater. 305, 529-533 (Pubitemid 44279929)
Weller, D., Moser, A., Folks, L., Best, M. E., Lee, W., Toney, M. F., and Schwickert, M. (2000) High ku materials approach to 100 gbits/in2 IEEE Trans. Magn. 36, 10-15
Laurent, S. and Mahmoudi, M. (2010) Superparamagnetic Iron Oxide Nanoparticles for Hyperthermia, Adv. Colloid Interface Sci. Under review.
Casula, M. F., Floris, P., Innocenti, C., Lascialfari, A., Marinone, M., Corti, M., Sperling, R. A., Parak, W. J., and Sangregorio, C. (2010) Magnetic resonance imaging contrast agents based on iron oxide superparamagnetic ferrofluids Chem. Mater. 22, 1739-1748
Boni, A., Marinone, M., Innocenti, C., Sangregorio, C., Corti, M., Lascialfari, A., Mariani, M., Orsini, F., Poletti, G., and Casula, M. F. (2008) Magnetic and relaxometric properties of Mn ferrites J. Phys. D: Appl. Phys. 41, 134021-134027
Corti, M., Lascialfari, A., Micotti, E., Castellano, A., Donativi, M., Quarta, A., Cozzoli, P. D., Manna, L., Pellegrino, T., and Sangregorio, C. (2008) Magnetic properties of novel superparamagnetic MRI contrast agents based on colloidal nanocrystals J. Magn. Magn. Mater. 320, e320-e323
Berret, J.-F., Schonbeck, N., Gazeau, F., El Kharrat, D., Sandre, O., Vacher, A., and Airiau, M. (2006) Controlled Clustering of Superparamagnetic Nanoparticles Using Block Copolymers: Design of New Contrast Agents for Magnetic Resonance Imaging J. Am. Chem. Soc. 128, 1755-1761 (Pubitemid 43214892)
Allemann, E., Leroux, J. C., and Gurny, R. (1998) Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics Adv. Drug Delivery Rev. 34, 171-189 (Pubitemid 28535111)
Constantinides, P. P., Chaubal, M. V., and Shorr, R. (2008) Advances in lipid nanodispersions for parenteral drug delivery and targeting Adv. Drug Delivery Rev. 60, 757-767
Hamidi, M., Azadi, A., and Rafiei, P. (2008) Hydrogel nanoparticles in drug delivery Adv. Drug Delivery Rev. 60, 1638-1649
Matsumura, Y. (2008) Poly(amino acid) micelle nanocarriers in preclinical and clinical studies Adv. Drug Delivery Rev. 60, 899-914
Otsuka, H., Nagasaki, Y., and Kataoka, K. (2003) PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Delivery Rev. 55, 403-419 (Pubitemid 36293792)
Kamei, K., Mukai, Y., Kojima, H., Yoshikawa, T., Yoshikawa, M., Kiyohara, G., Yamamoto, T. A., Yoshioka, Y., Okada, N., Seino, S., and Nakagawa, S. (2009) Direct cell entry of gold/iron-oxide magnetic nanoparticles in adenovirus mediated gene delivery Biomaterials 30, 1809-1814
Mahmoudi, M., Milani, A. S., and Stroeve, P. (2010) Surface Architecture of Superparamagnetic Iron Oxide Nanoparticles for Application in Drug Delivery and Their Biological Response: A Review Int. J. Biomed. Nanosci. Nanotechnol. 1, 164-201
Mahmoudi, M., Sant, S., Wang, B., Laurent, S., and Sen, T. (2011) Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy, Adv. Drug Delivery Rev. In press. DOI: 10.1016/j.addr.2010.05.006.
Ge, J., Hu, Y., Biasini, M., Beyermann, W. P., and Yin, Y. (2007) Superparamagnetic Magnetite Colloidal Nanocrystal Clusters Angew. Chem. 119, 4420-4423
Nel, A. E., Madler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., and Thompson, M. (2009) understanding biophysicochemical interactions at the nano-bio interface Nat. Mater. 8, 543-557
Mahmoudi, M., Serpooshan, V., and Laurent, S. (2011) Engineered nanoparticles for biomolecular imaging, Nanomedicine, in revision.
Mahmoudi, M., Simchi, A., Imani, M., and Hafeli, U. O. (2009) Superparamagnetic iron oxide nanoparticles with rigid cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery J. Phys. Chem. C 113, 8124-8131
Arbab, A. S., Bashaw, L. A., Miller, B. R., Jordan, E. K., Lewis, B. K., Kalish, H., and Frank, J. A. (2003) Characterization of Biophysical and Metabolic Properties of Cells Labeled with Superparamagnetic Iron Oxide Nanoparticles and Transfection Agent for Cellular MR Imaging Radiology 229, 838-846 (Pubitemid 37467591)
Foote, R. S., Lee, J. W., Jin, S., Leach, J. C., and Ye, K. (2009) Nanoparticle-Mediated Gene Delivery, in Micro and Nano Technologies in Bioanalysis, pp 547 - 557, Humana Press.
Ito, A., Takizawa, Y., Honda, H., Hata, K., Kagami, H., Ueda, M., and Kobayashi, T. (2004) Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells Tissue Eng. 10, 833-840 (Pubitemid 38880402)
US demand for nanotechnologymedical products to approach $53 billion in 2011-Report. nanotechwire.com [online News Release] 2007 March 16, 2007 [cited July 3, 2008]; available from http://nanotechwire.com/news.asp?nid= 4446.
Jones, C. F. and Grainger, D. W. (2009) In vitro assessments of nanomaterial toxicity Adv. Drug Delivery Rev. 61, 438-456
Aillon, K. L., Xie, Y., El-Gendy, N., Berkland, C. J., and Forrest, M. L. (2009) Effects of nanomaterial physicochemical properties on in vivo toxicity Adv. Drug Delivery Rev. 61, 457-466
Mahmoudi, M., Simchi, A., and Imani, M. (2010) Recent Advances in Surface Engineering of Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications J. Iran. Chem. Soc. 7, S1-S27
Gao, J. and Xu, B. (2009) Applications of nanomaterials inside cells Nano Today 4, xxx-xxx
Arruebo, M., Fernádez-Pacheco, R., Ibarra, M. R., and Santamaría, J. (2007) Magnetic nanoparticles for drug delivery Nano Today 2, 22-32 (Pubitemid 46695431)
Laurent, S., Bridot, J. L., Vander Elst, L., and Muller, R. (2010) Magnetic iron oxide nanoparticles for biomedical applications Future Med. Chem. 2, 427-449
Mahmoudi, M., Sardari, S., Shokrgozar, M. A., Laurent, S., and Stroeve, P. (2011) Interaction of superparamagnetic iron oxide nanoparticles with human transferrin: Irreversible changes in human transferrin conformation, Nanoscale, In press. DOI: 10.1039/c0nr00733a.
Mahmoudi, M., Shokrgozar, M. A., Simchi, A., Imani, M., Milani, A. S., Stroeve, P., Vali, H., Hafeli, U. O., and Bonakdar, S. (2009) Multiphysics flow modeling and in vitro toxicity of iron oxide nanoparticles coated with poly(vinyl alcohol) J. Phys. Chem. C 113, 2322-2331
Mahmoudi, M., Simchi, A., and Imani, M. (2009) Cytotoxicity of uncoated and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles J. Phys. Chem. C 113, 9573-9580
Mahmoudi, M., Simchi, A., Imani, M., Milani, A. S., and Stroeve, P. (2008) Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging J. Phys. Chem. B 112, 14470-14481
Mahmoudi, M., Simchi, A., Imani, M., Milani, A. S., and Stroeve, P. (2009) An in vitro study of bare and poly(ethylene glycol)-co-fumarate-coated superparamagnetic iron oxide nanoparticles: A new toxicity identification procedure Nanotechnology 20, 225104
Mahmoudi, M., Simchi, A., Imani, M., Shokrgozar, M. A., Milani, A. S., Hafeli, U. O., and Stroeve, P. (2010) A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles Colloids Surf., B 75, 300-309
Mahmoudi, M., Simchi, A., Imani, M., Stroeve, P., and Sohrabi, A. (2010) Templated growth of superparamagnetic iron oxide nanoparticles by temperature programming in the presence of poly(vinyl alcohol) Thin Solid Films 518, 4281-4289
Mahmoudi, M., Simchi, A., Milani, A. S., and Stroeve, P. (2009) Cell toxicity of superparamagnetic iron oxide nanoparticles J. Colloid Interface Sci. 336, 510-518
Mahmoudi, M., Simchi, A., Vali, H., Imani, M., Shokrgozar, M. A., Azadmanesh, K., and Azari, F. (2009) Cytotoxicity and cell cycle effects of bare and poly(vinyl alcohol)-coated iron oxide nanoparticles in mouse fibroblasts Adv. Eng. Mater. 11, B243-B250
Papaefthymiou, G. C. (2009) Nanoparticle magnetism Nano Today 4, 438-447
Kohler, N., Fryxell, G. E., and Zhang, M. (2004) A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents J. Am. Chem. Soc. 126, 7206-7211 (Pubitemid 38747770)
Reinl, H. M., Peller, M., Hagmann, M., Turner, P., Issels, R. D., and Reiser, M. (2005) Ferrite-enhanced MRI monitoring in hyperthermia J. Magn. Reson. Imaging 23, 1017-1020 (Pubitemid 41823937)
Shultz, M. D., Ulises Reveles, J., Khanna, S. N., and Carpenter, E. E. (2007) Reactive nature of dopamine as a surface functionalization agent in iron oxide nanoparticles J. Am. Chem. Soc. 129, 2482-2487 (Pubitemid 46364053)
Wang, D., He, J., Rosenzweig, N., and Rosenzweig, Z. (2004) Superparamagnetic Fe2O3 beads-CdSe/ZnS quantum dots core-shell nanocomposite particles for cell separation Nano Lett. 4, 409-413 (Pubitemid 38402623)
Gupta, A. K., Naregalkar, R. R., Vaidya, V. D., and Gupta, M. (2007) Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications Nanomedicine 2, 23-39 (Pubitemid 46845774)
Gupta, A. K. and Gupta, M. (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 26, 3995-4021 (Pubitemid 40044762)
Karlsson, H. L., Cronholm, P., Gustafsson, J., and Muller, L. (2008) Copper oxide nanoparticles are highly toxic: A comparison between metal oxide nanoparticles and carbon nanotubes Chem. Res. Toxicol. 21, 1726-1732
Thorek, D. L. J., Chen, A. K., Czupryna, J., and Tsourkas, A. (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging Ann. Biomed. Eng. 34, 23-38
Lu, J., Yang, S., Ng, K. M., Su, C. H., Yeh, C. S., Wu, Y. N., and Shieh, D. B. (2006) Solid-state synthesis of monocrystalline iron oxide nanoparticle based ferrofluid suitable for magnetic resonance imaging contrast application Nanotechnology 17, 5812-5820 (Pubitemid 46069956)
Bonnemain, B. (1998) Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications. A review J. Drug Targeting 6, 167-174 (Pubitemid 29034284)
Weissleder, R., Elizondo, G., Wittenberg, J., Rabito, C. A., Bengele, H. H., and Josephson, L. (1990) Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging Radiology 175, 489-493 (Pubitemid 20135290)
Mornet, S., Vasseur, S., Grasset, F., and Duguet, E. (2004) Magnetic nanoparticle design for medical diagnosis and therapy J. Mater. Chem. 14, 2161-2175
Passirani, C., Barratt, G., Devissaguet, J. P., and Labarre, D. (1998) Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) Pharm. Res. 15, 1046-1050 (Pubitemid 28356921)
Soenen, S. J. H. and De Cuyper, M. (2009) Assessing cytotoxicity of (iron oxide-based) nanoparticles: An overview of different methods exemplified with cationic magnetoliposomes Contrast Media Mol. Imaging 4, 207-219
Wu, Y. J., Muldoon, L. L., Varallyay, C., Markwardt, S., Jones, R. E., and Neuwelt, E. A. (2007) In vivo leukocyte labeling with intravenous ferumoxides/protamine sulfate complex and in vitro characterization for cellular magnetic resonance imaging Am. J. Physiol. 293, C1698-C1708
Gupta, A. K., Berry, C., Gupta, M., and Curtis, A. (2003) Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis IEEE Tran. Nanobiosci. 2, 255-261
Gupta, A. K. and Wells, S. (2004) Surface-Modified Superparamagnetic Nanoparticles for Drug Delivery: Preparation, Characterization, and Cytotoxicity Studies IEEE Trans. Nanobiosci. 3, 66-73
Kim, J. S., Yoon, T. J., Yu, K. N., Mi, S. N., Woo, M., Kim, B. G., Lee, K. H., Sohn, B. H., Park, S. B., Lee, J. K., and Cho, M. H. (2006) Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells J. Vet. Sci. 7, 321-326 (Pubitemid 44885830)
Muller, K., Skepper, J. N., Posfai, M., Trivedi, R., Howarth, S., Corot, C., Lancelot, E., Thompson, P. W., Brown, A. P., and Gillard, J. H. (2007) Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro Biomaterials 28, 1629-1642 (Pubitemid 46098969)
Mykhaylyk, O., Antequera, Y. S., Vlaskou, D., and Plank, C. (2007) Generation of magnetic nonviral gene transfer agents and magnetofection in vitro Nat. Protoc. 2, 2391-2411
Ge, Y., Zhang, Y., He, S., Nie, F., Teng, G., and Gu, N. (2009) Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging Nanoscale Res. Lett. 4, 287-295
Farrell, E., Wielopolski, P., Pavljasevic, P., Kops, N., Weinans, H., Bernsen, M. R., and van Osch, G. J. V. M. (2009) Cell labelling with superparamagnetic iron oxide has no effect on chondrocyte behaviour Osteoarthritis Cartilage 17, 958-964
Chorny, M., Polyak, B., Alferiev, I. S., Walsh, K., Friedman, G., and Levy, R. J. (2007) Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles FASEB J. 21, 2510-2519 (Pubitemid 47230680)
Samanta, B., Yan, H., Fischer, N. O., Shi, J., Jerry, D. J., and Rotello, V. M. (2008) Protein-passivated Fe3O4 nanoparticles: Low toxicity and rapid heating for thermal therapy J. Mater. Chem. 18, 1204-1208 (Pubitemid 351342256)
Huang, G., Diakur, J., Xu, Z., and Wiebe, L. I. (2008) Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles Int. J. Pharm. 360, 197-203
Babic, M., Horok, D., Jendelová, P., Glogarová, K., Herynek, V., Trchova, M., Likavoanová, K., Lesny, P., Pollert, E., Hajek, M., and Sykova, E. (2009) Poly(N, N -dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling Bioconjugate Chem. 20, 283-294
Hussain, S. M., Hess, K. L., Gearhart, J. M., Geiss, K. T., and Schlager, J. J. (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells Toxicol. in Vitro 19, 975-983 (Pubitemid 41563236)
Pawelczyk, E., Arbab, A. S., Chaudhry, A., Balakumaran, A., Robey, P. G., and Frank, J. A. (2008) In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: Implications for cellular therapy Stem Cells 26, 1366-1375
Corot, C., Robert, P., Idée, J. M., and Port, M. (2006) Recent advances in iron oxide nanocrystal technology for medical imaging Adv. Drug Delivery Rev. 58, 1471-1504 (Pubitemid 44820503)
Muller, R. N., Roch, A., Colet, J. M., Ouakssim, A., and Gillis, P. (2001) Particulate magnetic contrast agents, in The chemistry of contrast agents in medical magnetic resonance imaging (Merbach, A.E. and Toth, E., Eds.), Chapter 10, pp 417 - 435, Wiley.
Ouakssim, A., Fastrez, S., Roch, A., Laurent, S., Gossuin, Y., Pierart, C., Vander Elst, L., and Muller, R. N. (2004) Control of the synthesis of magnetic fluids by relaxometry and magnetometry J. Magn. Magn. Mater. 272-276, e1711-e1713
Sofue, K., Tsurusaki, M., Miyake, M., Sakurada, A., Arai, Y., and Sugimura, K. (2010) Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients, Eur. Radiol. In press.
Zhang, J. X., Dang, S. C., Zhang, Y., Sha, X., Zhang, L. R., Wei, C. S., Chen, M., and Jiang, D. L. (2010) MRI shows clodronate-liposomes attenuating liver injury in rats with severe acute pancreatitis Hepatobiliary Pancreat Dis. Int. 9, 192-200
Zhou, B., Shan, H., Li, D., Jiang, Z. B., Qian, J. S., Zhu, K. S., Huang, M. S., and Meng, X. C. (2010) MR tracking of magnetically labeled mesenchymal stem cells in rats with liver fibrosis J. Magn. Reson. Imaging 28, 394-399
Vellinga, M. M., Vrenken, H., Hulst, H. E., Polman, C. H., Uitdehaag, B. M., Pouwels, P. J., Barkhof, F., and Geurts, J. J. (2009) Use of ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI to demonstrate diffuse inflammation in the normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients: an exploratory study J. Magn. Reson. Imaging 29, 774-779
Stoll, G. and Bendszus, M. (2010) New approaches to neuroimaging of central nervous system inflammation Curr. Opin. Neurol. 23, 282-286
Bonnemain, B. (2008) Nanoparticles: the industrial viewpoint. Applications in diagnostic imaging Ann. Pharm. Fr. 66, 263-267
Tang, T. Y., Howarth, S. P. S., Miller, S. R., Graves, M. J., U-King-Im, J. M., Li, Z. Y., Walsh, S. R., Patterson, A. J., Kirkpatrick, P. J., Warburton, E. A., Varty, K., Gaunt, M. E., and Gillard, J. H. (2008) Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal Stenosis Stroke 39, 2144-2147
Jiang, T., Zhang, C., Zheng, X., Xu, X., Xie, X., Liu, H., and Liu, S. (2009) Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner Int. J. Nanomed. 4, 241-249
Das, M., Mishra, D., Dhak, P., Gupta, S., Maiti, T. K., Basak, A., and Pramanik, P. (2009) Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging Small 5, 2883-2893
Kiessling, I., Bzyl, J., and Kiessling, F. (2010) Molecular ultrasound imaging and its potential for paediatric radiology, Pediatr. Radiol. In press.
Meier, R., Henning, T. D., Boddington, S., Tavri, S., Arora, S., Piontek, G., Rudelius, M., Corot, C., and Daldrup-Link, H. E. (2010) Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133 Radiology 255, 527-535
Sudimack, J. and Lee, R. J. (2000) Drug Targeting via the Folate Receptor Adv. Drug Delivery Rev. 41, 147-162 (Pubitemid 30122955)
Choi, H., Choi, S. R., Zhou, R., Kung, H. F., and Chen, I. W. (2004) Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery Acad. Radiol. 11, 996-1004 (Pubitemid 39220809)
Hogemann, D., Josephson, L., Weissleder, R., and Basilion, J. P. (2000) Improvement of MRI probes to allow efficient detection of gene expression Bioconjugate Chem. 11, 941-946
Hogemann-Savellano, D., Bost, E., Blondet, C., Sato, F., Abe, T., Josephson, L., Weissleder, R., Gaudet, J., Sgroi, D., Peters, P. J., and Basilion, J. P. (2003) The Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer Neoplasia 5, 495-506 (Pubitemid 38045087)
Kresse, M., Wagner, S., Pfefferer, D., Lawaczeck, R., Elste, V., and Semmler, W. (1998) Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways Magn. Reson. Med. 40, 236-242 (Pubitemid 28361526)
Radermacher, K. A., Beghein, N., Boutry, S., Laurent, S., Vander Elst, L., Muller, R. N., Jordan, B. F., and Gallez, B. (2009) In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy Invest. Radiol. 44, 398-404
Boutry, S., Laurent, S., Elst, L. V., and Muller, R. N. (2006) Specific E-selectin targeting with a superparamagnetic MRI contrast agent Contrast Media Mol. Imaging 1, 15-22
Sigovan, M., Boussel, L., Sulaiman, A., Sappey-Marinier, D., Alsaid, H., Desbleds-Mansard, C., Ibarrola, D., Gamondès, D., Corot, C., Lancelot, E., Raynaud, J. S., Vives, V., Laclédère, C., Violas, X., Douek, P. C., and Canet-Soulas, E. (2009) Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model Radiology 252, 401-409
Stoll, G. and Bendszus, M. (2010) New approaches to neuroimaging of central nervous system inflammation Curr. Opin. Neurol. 23, 282-286
Stoll, G. and Bendszus, M. (2009) Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging Neuroscience 158, 1151-1160
Nighoghossian, N., Wiart, M., and Berthezene, Y. (2008) Novel applications of magnetic resonance imaging to image tissue inflammation after stroke J. Neuroimaging 18, 349-352
Nighoghossian, N., Wiart, M., Cakmak, S., Berthezène, Y., Derex, L., Cho, T. H., Nemoz, C., Chapuis, F., Tisserand, G. L., Pialat, J. B., Trouillas, P., Froment, J. C., and Hermier, M. (2007) Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients Stroke 38, 303-307 (Pubitemid 46184299)
Saleh, A., Schroeter, M., Ringelstein, A., Hartung, H. P., Siebler, M., Mödder, U., and Jander, S. (2007) Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke Stroke 38, 2733-2737 (Pubitemid 47494011)
Jander, S., Schroeter, M., and Saleh, A. (2007) Imaging inflammation in acute brain ischemia Stroke 38, 642-645 (Pubitemid 46184233)
Cengelli, F., Maysinger, D., Tschudi-Monnet, F., Montet, X., Corot, C., Petri-Fink, A., Hofmann, H., and Juillerat-Jeanneret, L. (2006) Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures J. Pharmacol. Exp. Ther. 318, 108-116
Bierry, G., Jehl, F., Neuville, A., Lefevre, S., Robert, P., Kremer, S., and Dietemann, J. L. (2010) MRI of macrophages in infectious knee synovitis AJR, Am. J. Roentgenol. 194, W521-W526
Bierry, G., Jehl, F., Boehm, N., Robert, P., Dietemann, J. L., and Kremer, S. (2009) Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation Eur. Radiol. 19, 1604-1611
Truijers, M., Fütterer, J. J., Takahashi, S., Heesakkers, R. A., Blankensteijn, J. D., and Barentsz, J. O. (2009) In vivo imaging of the aneurysm wall with MRI and a macrophage-specific contrast agent AJR, Am. J. Roentgenol. 193, W437-W441
Saito, T., Abe, T., Tsuchiya, T., Satoh, Y., Kenjo, A., Kimura, T., and Gotoh, M. (2008) Sequential magnetic resonance imaging for evaluation of Kupffer cell function Hepatogastroenterology 55, 596-599 (Pubitemid 351741509)
Hyafil, F., Laissy, J. P., Mazighi, M., Tchétché, D., Louedec, L., Adle-Biassette, H., Chillon, S., Henin, D., Jacob, M. P., Letourneur, D., and Feldman, L. J. (2006) Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: Relationship between signal loss and macrophage infiltration Arterioscler., Thromb., Vasc. Biol. 26, 176-181 (Pubitemid 43732246)
Yancy, A. D., Olzinski, A. R., Hu, T. C. C., Lenhard, S. C., Aravindhan, K., Gruver, S. M., Jacobs, P. M., Willette, R. N., and Jucker, B. M. (2005) Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling J. Magn. Reson. Imaging 21, 432-442 (Pubitemid 40446439)
Ruehm, S. G., Corot, C., Vogt, P., Kolb, S., and Debatin, J. F. (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits Circulation 103, 415-422 (Pubitemid 32105982)
Van Kasteren, S. I., Campbell, S. J., Serres, S., Anthony, D. C., Sibson, N. R., and Davis, B. G. (2009) Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease Proc. Natl. Acad. Sci. U.S.A. 106, 18-23
Garca, I., Marradi, M., and Penadés, S. (2010) Glyconanoparticles: Multifunctional nanomaterials for biomedical applications Nanomedicine 5, 777-792
Lepenies, B. and Seeberger, P. H. (2010) The promise of glycomics, glycan arrays and carbohydrate-based vaccines Immunopharmacol. Immunotoxicol. 32, 196-207
Ei-Boubbou, K., Zhu, D. C., Vasileiou, C., Borhan, B., Prospen, D., Wei, L. I., and Huang, X. (2010) Magnetic glyco-nanoparticles: A tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging J. Am. Chem. Soc. 132, 4490-4499
Geraldes, C. F., Djanashvili, K., and Peters, J. A. (2010) Glycoconjugate probes and targets for molecular imaging using magnetic resonance Future Med. Chem. 2, 409-425
McAteer, M. A., Akhtar, A. M., von zur Muhlen, C., and Choudhury, R. P. (2010) An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide Atherosclerosis 209, 18-27
Jin, A. Y., Tuor, U. I., Rushforth, D., Filfil, R., Kaur, J., Ni, F., Tomanek, B., and Barber, P. A. (2009) Magnetic resonance molecular imaging of post-stroke neuroinflammation with a P-selectin targeted iron oxide nanoparticle Contrast Media Mol. Imaging 4, 305-311
Berger, C., Hiestand, P., Kindler-Baumann, D., Rudin, M., and Rausch, M. (2006) Analysis of lesion development during acute inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visualization of macrophage infiltration, demyelination and blood-brain barrier damage NMR Biomed. 19, 101-107 (Pubitemid 43250795)
Cunningham, C. H., Arai, T., Yang, P. C., McConnell, M. V., Pauly, J. M., and Conolly, S. M. (2005) Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles Magn. Reson. Med. 53, 999-1005 (Pubitemid 40627773)
Anderson, S. A., Rader, R. K., Westlin, W. F., Null, C., Jackson, D., Lanza, C. M., Wickline, S. A., and Kotyk, J. J. (2000) Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles Magn. Reson. Med. 44, 433-439
Polyak, B. and Friedman, G. (2009) Magnetic targeting for site-specific drug delivery: applications and clinical potential Expert Opin. Drug Delivery 6, 53-70
Amiri, H., Mahmoudi, M., and Lascialfari, A. (2011) Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent, Nanoscale. DOI: 10.1039/c0nr00603c.
Jalilian, A. R., Panahifar, A., Mahmoudi, M., Akhlaghi, M., and Simchi, A. (2009) Preparation and biological evaluation of [67Ga]-labeled- superparamagnetic nanoparticles in normal rats Radiochim. Acta 97, 51-56
Bartolozzi, C., Lencioni, R., Donati, F., and Cioni, D. (1999) Abdominal MR: Liver and pancreas Eur. Radiol. 9, 1496-1512
Meng, J., Fan, J., Galiana, G., Branca, R. T., Clasen, P. L., Ma, S., Zhou, J., Leuschner, C., Kumar, C. S. S. R., Hormes, J., Otiti, T., Beye, A. C., Harmer, M. P., Kiely, C. J., Warren, W., Haataja, M. P., and Soboyejo, W. O. (2009) LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI Mater. Sci. Eng., C 29, 1467-1479
Shubayev, V. I., Pisanic, Ii, T. R., and Jin, S. (2009) Magnetic nanoparticles for theragnostics Adv. Drug Delivery Rev. 61, 467-477
Matthews, P. M. (2009) Brain Imaging of Multiple Sclerosis: the Next 10 Years Neuroimaging Clin. North Am. 19, 101-112
Hauser, S. L. and Oksenberg, J. R. (2006) The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration Neuron 52, 61-76 (Pubitemid 44466355)
Baranzini, S. E., Galwey, N. W., Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B. M. J., Kappos, L., Polman, C. H., Matthews, P. M., Hauser, S. L., Gibson, R. A., Oksenberg, J. R., and Barnes, M. R. (2009) Pathway and network-based analysis of genome-wide association studies in multiple sclerosis Hum. Mol. Genet. 18, 2078-2090
Baranzini, S. E., Srinivasan, R., Khankhanian, P., Okuda, D. T., Nelson, S. J., Matthews, P. M., Hauser, S. L., Oksenberg, J. R., and Pelletier, D. (2010) Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis Brain 133, 2603-2611
Mikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B., Canron, M. H., Franconi, J. M., Boiziau, C., and Petry, K. G. (2010) Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of Multiple Sclerosis. Amelioration of clinical status by M2 activated monocyte administration, Mult. Scler., PMID: 20813772.
Dousset, V., Brochet, B., Deloire, M. S. A., Lagoarde, L., Barroso, B., Caille, J. M., and Petry, K. G. (2006) MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium American Journal of Neuroradiology 27, 1000-1005 (Pubitemid 44897675)
Matthews, P. M. and Comley, R. (2009) Advances in the molecular imaging of multiple sclerosis Expert Review of Clinical Immunology 5, 765-777
Conturo, T. E., Akbudak, E., Kotys, M. S., Chen, M. L., Chun, S. J., Hsu, R. M., Sweeney, C. C., and Markham, J. (2005) Arterial input functions for dynamic susceptibility contrast MRI: Requirements and signal options J. Magn. Reson. Imaging 22, 697-703 (Pubitemid 41741233)
Jalilian, A. R., Hosseini-Salekdeh, S. L., Mahmoudi, M., Yousefnia, H., Majdabadi, A., and Pouladian, M. (2010) Preparation and biological evaluation of radiolabeled-folate embedded superparamagnetic nanoparticles in wild-type rats, J. Radioanal. Nucl. Chem. In press.
Vellinga, M. M., Oude Engberink, R. D., Seewann, A., Pouwels, P. J. W., Wattjes, M. P., Van Der Pol, S. M. A., Pering, C., Polman, C. H., De Vries, H. E., Geurts, J. J. G., and Barkhof, F. (2008) Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement Brain 131, 800-807 (Pubitemid 351294725)
Harris, V. K. and Sadiq, S. A. (2009) Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making Mol. Diagn. Ther. 13, 225-244
Cheng, M. M., Cuda, G., and Bunimovich, Y. L. (2006) Nanotechnologies for biomolecular detection and medical diagnostics Curr. Opin. Chem. Biol. 10, 11-19 (Pubitemid 43202282)
Lin, L. N., Liu, Q., Song, L., Liu, F. F., and Sha, J. X. (2010) Recent advances in nanotechnology based drug delivery to the brain, Cytotechnology, in press.
Calvo, P., Gouritin, B., Villarroya, H., Eclancher, F., Giannavola, C., Klein, C., Andreux, J. P., and Couvreur, P. (2002) Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat Eur. J. Neurosci. 15, 1317-1326 (Pubitemid 35477993)
Neuberger, T., Schpf, B., Hofmann, H., Hofmann, M., and von Rechenberg, B. (2005) Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system J. Magn. Magn. Mater. 293, 483-496 (Pubitemid 40608969)
Abu-Lail, N. I., Kaholek, M., LaMattina, B., Clark, R. L., and Zauscher, S. (2006) Micro-cantilevers with end-grafted stimulus-responsive polymer brushes for actuation and sensing Sens. Actuators, B 114, 371-378 (Pubitemid 43276202)
Tanaka, T. and Fillmore, D. J. (1979) Kinetics of swelling of gels J. Chem. Phys. 70, 1214-1218
Santer, S., Kopyshev, A., Donges, J., Yang, H. K., and Ruhe, J. (2006) Dynamically reconfigurable polymer films: Impact on nanomotion Adv. Mater. 18, 2359-2362 (Pubitemid 44495395)
Motornov, M., Sheparovych, R., Tokarev, I., Roiter, Y., and Minko, S. (2007) Nonwettable thin films from hybrid polymer brushes can be hydrophilic Langmuir 23, 13-19 (Pubitemid 46129698)
Crowe-Willoughby, J. A. and Genzer, J. (2009) Formation and properties of responsive siloxane-based polymeric surfaces with tunable surface reconstruction kinetics Adv. Funct. Mater. 19, 460-469
Stuart, M. A. C., Huck, W. T. S., Genzer, J., Muller, M., Ober, C., Stamm, M., Sukhorukov, G. B., Szleifer, I., Tsukruk, V. V., Urban, M., Winnik, F., Zauscher, S., Luzinov, I., and Minko, S. (2010) Emerging applications of stimuli-responsive polymer materials Nat. Mater. 9, 101-113
Paolicelli, D., Direnzo, V., and Trojano, M. (2009) Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis Biologics 3, 369-376
Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Rousseaux, O., Toubeau, G., Vander Elst, L., Corot, C., and Muller, R. N. (2009) Molecular MRI of VCAM-1 expression in inflammatory lesions by using a peptide-vectorized paramagnetic imaging probe J. Med. Chem. 52, 4725-4742
